Journal of Immunology 2014-06-15

Caspase-8 acts as a molecular rheostat to limit RIPK1- and MyD88-mediated dendritic cell activation.

Carla M Cuda, Alexander V Misharin, Angelica K Gierut, Rana Saber, G Kenneth Haines, Jack Hutcheson, Stephen M Hedrick, Chandra Mohan, G Scott Budinger, Christian Stehlik, Harris Perlman

文献索引：J. Immunol. 192(12) , 5548-60, (2014)

全文：HTML全文

摘要

Caspase-8, an executioner enzyme in the death receptor pathway, was shown to initiate apoptosis and suppress necroptosis. In this study, we identify a novel, cell death-independent role for caspase-8 in dendritic cells (DCs): DC-specific expression of caspase-8 prevents the onset of systemic autoimmunity. Failure to express caspase-8 has no effect on the lifespan of DCs but instead leads to an enhanced intrinsic activation and, subsequently, more mature and autoreactive lymphocytes. Uncontrolled TLR activation in a RIPK1-dependent manner is responsible for the enhanced functionality of caspase-8-deficient DCs, because deletion of the TLR-signaling mediator, MyD88, ameliorates systemic autoimmunity induced by caspase-8 deficiency. Taken together, these data demonstrate that caspase-8 functions in a cell type-specific manner and acts uniquely in DCs to maintain tolerance. Copyright © 2014 by The American Association of Immunologists, Inc.